B lymphocytes in neuromyelitis optica.
B lymphocytes in neuromyelitis optica.
复制标题
b淋巴细胞神经霉炎。
DOI:
10.1212/nxi.0000000000000104
复制
发表时间:
2015-06
期刊:
影响因子:
--
通讯作者:
Stadelmann C
中科院分区:
文献类型:
--
作者:
Bennett JL;O'Connor KC;Bar-Or A;Zamvil SS;Hemmer B;Tedder TF;von Büdingen HC;Stuve O;Yeaman MR;Smith TJ;Stadelmann C
Neuromyelitis optica (NMO) is an inflammatory autoimmune disorder of the CNS that predominantly affects the spinal cord and optic nerves. A majority (approximately 75%) of patients with NMO are seropositive for autoantibodies against the astrocyte water channel aquaporin-4 (AQP4). These autoantibodies are predominantly IgG1, and considerable evidence supports their pathogenicity, presumably by binding to AQP4 on CNS astrocytes, resulting in astrocyte injury and inflammation. Convergent clinical and laboratory-based investigations have indicated that B cells play a fundamental role in NMO immunopathology. Multiple mechanisms have been hypothesized: AQP4 autoantibody production, enhanced proinflammatory B cell and plasmablast activity, aberrant B cell tolerance checkpoints, diminished B cell regulatory function, and loss of B cell anergy. Accordingly, many current off-label therapies for NMO deplete B cells or modulate their activity. Understanding the role and mechanisms whereby B cells contribute to initiation, maintenance, and propagation of disease activity is important to advancing our understanding of NMO pathogenesis and developing effective disease-specific therapies.